1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Funding cycle closed (2025 deadline was June 22, 2025). Check funder for 2026 cycle announcement.
Historical funding: $150,000
Prior eligibility: Open to researchers 35 years of age and under, including early-career professors and postdocs, working on human immunology and vaccine development.
Michelson Prizes: Next Generation Grants is sponsored by Human Immunome Project and Michelson Medical Research Foundation. These grants are awarded annually to early-career scientists for innovative, high-risk projects in human immunology, vaccine discovery, and immunotherapy research for major global diseases, aiming to advance disruptive concepts that address major global diseases and unravel the complexities of the human immune system.
The memorandum of agreement was signed August 4 and 5, disclosed by House appropriators on September 3, and runs through 2036. It names no dollar figure. Here is what is actually established, what is still speculation, and what researchers holding or planning NIAID biodefense awards should do before September 30.
Read articleOn August 26, 2026, NSF named the STC class of 2026: TEMPEST at Michigan State, GENIE at Northwestern, and a human-robot co-adaptation center at UT Austin. $90 million total, $6 million a year each. The 2023 class was four centers and $120 million. The award size is intact; the shelf space shrank 25 percent — and that is the number that should reshape how you plan a center proposal.
Read articleDARPA BTO pre-released four FY26 SBIR/STTR topics on April 30, 2026, with proposals due June 3. Two topics — SWiFT and EXPOSITION — offer Direct-to-Phase-II awards up to $1.5M, bypassing the standard Phase I gate. Here is what each topic is actually solving, why the DP2 structure matters, and how small biotech, surgical robotics, and battlefield-medicine teams should decide whether to compete.
Read article